Laura Nigi

2.5k total citations
40 papers, 1.1k citations indexed

About

Laura Nigi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Laura Nigi has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 15 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Cancer Research. Recurrent topics in Laura Nigi's work include Pancreatic function and diabetes (19 papers), MicroRNA in disease regulation (14 papers) and Diabetes and associated disorders (13 papers). Laura Nigi is often cited by papers focused on Pancreatic function and diabetes (19 papers), MicroRNA in disease regulation (14 papers) and Diabetes and associated disorders (13 papers). Laura Nigi collaborates with scholars based in Italy, Belgium and United Kingdom. Laura Nigi's co-authors include Francesco Dotta, Guido Sebastiani, Giuseppina Emanuela Grieco, Noemi Brusco, Caterina Formichi, Giuliana Ventriglia, Giada Licata, Daniela Fignani, Francesca Mancarella and Décio L. Eizirik and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Laura Nigi

37 papers receiving 1.0k citations

Peers

Laura Nigi

SURGE

GENET

EDM

Xi Jia China

Tracy X. Cui United States

Lotte B. Nielsen Denmark

Francesca Di Rella Italy

Christopher F. MacManus United States

Jose Zavala‐Solorio United States

Sirong He China

Zongli Diao China

Philip K. Frykman United States

Kiyoshi Saitoh Japan

Xi Jia China

Laura Nigi

222 ×0.5

97 ×0.3

SURGE

79 ×0.2

80 ×0.3

GENET

318 ×1.1

EDM

Citations per year, relative to Laura Nigi Laura Nigi (= 1×) peers Xi Jia

Countries citing papers authored by Laura Nigi

Since Specialization

Citations

This map shows the geographic impact of Laura Nigi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Nigi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Nigi more than expected).

Fields of papers citing papers by Laura Nigi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Nigi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Nigi. The network helps show where Laura Nigi may publish in the future.

Co-authorship network of co-authors of Laura Nigi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Nigi. A scholar is included among the top collaborators of Laura Nigi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Nigi. Laura Nigi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nigi, Laura, et al.. (2025). Neutrophils in Type 1 Diabetes: Untangling the Intricate Web of Pathways and Hypothesis. Biomolecules. 15(4). 505–505.

Formichi, Caterina, Sonia Caprio, Laura Nigi, & Francesco Dotta. (2025). The impact of environmental pollution on metabolic health and the risk of non-communicable chronic metabolic diseases in humans. Nutrition Metabolism and Cardiovascular Diseases. 35(6). 103975–103975.

Sebastiani, Guido, Giuseppina Emanuela Grieco, Marco Bruttini, et al.. (2024). A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes. Cell Reports Medicine. 5(6). 101591–101591. 5 indexed citations

Nigi, Laura, et al.. (2023). 12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients. Diabetes Technology & Therapeutics. 26(2). 130–135. 4 indexed citations

Brusco, Noemi, Guido Sebastiani, Gianfranco Di Giuseppe, et al.. (2022). Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes. Diabetologia. 66(2). 354–366. 27 indexed citations

Grieco, Giuseppina Emanuela, Zein Mersini Besharat, Giada Licata, et al.. (2022). Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside. Translational research. 247. 137–157. 25 indexed citations

Grieco, Giuseppina Emanuela, Noemi Brusco, Daniela Fignani, et al.. (2022). Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation. Cell Death Discovery. 8(1). 340–340. 13 indexed citations

Grieco, Giuseppina Emanuela, Guido Sebastiani, Daniela Fignani, et al.. (2021). Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples. STAR Protocols. 2(3). 100606–100606. 8 indexed citations

Grieco, Giuseppina Emanuela, Daniela Fignani, Caterina Formichi, et al.. (2021). Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools. Frontiers in Immunology. 12. 682948–682948. 34 indexed citations

10.

Brozzetti, Annalisa, Eva Pericolini, Elena Bartoloni, et al.. (2020). Prevention and treatment of autoimmune diseases with plant virus nanoparticles. Science Advances. 6(19). eaaz0295–eaaz0295. 31 indexed citations

11.

Nigi, Laura, Noemi Brusco, Giuseppina Emanuela Grieco, et al.. (2020). Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes. Frontiers in Endocrinology. 11. 630–630. 24 indexed citations

12.

Fignani, Daniela, Giada Licata, Noemi Brusco, et al.. (2020). SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Frontiers in Endocrinology. 11. 596898–596898. 133 indexed citations

13.

Donato, Gianmarco de, Edoardo Pasqui, Francesco Setacci, et al.. (2018). Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options. Seminars in Vascular Surgery. 31(2-4). 66–75. 19 indexed citations

14.

Russell, Mark A., Shalinee Dhayal, Pia Leete, et al.. (2018). Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia. 61(11). 2344–2355. 55 indexed citations

15.

Sebastiani, Guido, et al.. (2017). Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?. Journal of Endocrinological Investigation. 40(6). 591–610. 73 indexed citations

16.

Solini, Anna, Guido Sebastiani, Laura Nigi, et al.. (2017). Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells. Diabetes & Metabolism. 43(6). 512–520. 46 indexed citations

17.

Sebastiani, Guido, Giuliana Ventriglia, Angela Stabilini, et al.. (2017). Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression. Scientific Reports. 7(1). 6897–6897. 51 indexed citations

18.

Sebastiani, Guido, Giuseppina Emanuela Grieco, Giuliana Ventriglia, et al.. (2016). MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells. Acta Diabetologica. 54(3). 265–281. 32 indexed citations

19.

Spagnuolo, Isabella, et al.. (2013). The case for virus-induced type 1 diabetes. Current Opinion in Endocrinology Diabetes and Obesity. 20(4). 292–298. 15 indexed citations

20.

Guarino, Elisa, et al.. (2012). Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 13(9). 1377–1384. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact